Marketing & Strategy
PRIME Awards 2023 finalists announced

The finalists for PRIME Awards 2023 have been named, with winners to be announced on Thursday the 9th November at the Sofitel Sydney Wentworth.
From the highest number of submissions in the history of PRIME, 55 entries have been successfully shortlisted by a joint panel of 26 judges across marketing, public relations, education, public health, and pharmaceutical sales.
Chair of Judges, David Cousins, said PRIME Awards continues to go from strength to strength with 2023 a record year for entries.
“In this context the commitment from our judges is incredible and I thank them for their ethical, objective, and thorough approach,” said Mr Cousins.
“Even after two rounds of online scoring, the quality of entries this year meant every category was highly competitive, making decisions for our finalist judges extremely challenging. Congratulations to everyone who entered.”
The complete list of finalists can be viewed via the PRIME Awards website. Tickets for the ceremony are now on sale.
PRIME Awards recognises and celebrates excellence within healthcare communications in the pharmaceutical and life sciences industry. Health Industry Hub is the media partner for the event.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo
The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]
MoreNews & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer
Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]
MoreNews & Trends - MedTech & Diagnostics

Vantive debuts as standalone business amid complex landscape of chronic kidney disease
Vantive, formerly Baxter’s Kidney Care business, has officially launched as a standalone company. The move follows Baxter’s completion of the […]
MoreNews & Trends - MedTech & Diagnostics

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program
An Australian medical technology company has introduced a test designed to identify obstructive sleep apnoea (OSA), broadening access to sleep […]
More